Medivir, Novartis Resolve Dispute Over Partially Overlapping Patents
Swedish specialized pharmaceutical company Medivir and Swiss drug maker Novartis have resolved a dispute over partially overlapping patents in the U.S. for antiviral combination products, the two companies said....To view the full article, register now.
Already a subscriber? Click here to view full article